217 related articles for article (PubMed ID: 36590596)
1. Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease.
Hu X; Fan R; Song W; Qing J; Yan X; Li Y; Duan Q; Li Y
Front Cell Infect Microbiol; 2022; 12():1061629. PubMed ID: 36590596
[TBL] [Abstract][Full Text] [Related]
2. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
Chai L; Luo Q; Cai K; Wang K; Xu B
BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
[TBL] [Abstract][Full Text] [Related]
3. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls.
Shah NB; Nigwekar SU; Kalim S; Lelouvier B; Servant F; Dalal M; Krinsky S; Fasano A; Tolkoff-Rubin N; Allegretti AS
Kidney360; 2021 Aug; 2(8):1261-1274. PubMed ID: 35369657
[TBL] [Abstract][Full Text] [Related]
4. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies.
Han S; Shang L; Lu Y; Wang Y
Front Cell Infect Microbiol; 2022; 12():904401. PubMed ID: 35656030
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.
Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S
Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes.
Dong Y; Chen J; Zhang Y; Wang Z; Shang J; Zhao Z
Front Cell Infect Microbiol; 2022; 12():1059692. PubMed ID: 36569195
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
9. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
[TBL] [Abstract][Full Text] [Related]
10. The microbiome and IgA nephropathy.
Haniuda K; Gommerman JL; Reich HN
Semin Immunopathol; 2021 Oct; 43(5):649-656. PubMed ID: 34664087
[TBL] [Abstract][Full Text] [Related]
11. Different Expression Patterns of Toll-Like Receptor mRNAs in Blood Mononuclear Cells of IgA Nephropathy and IgA Vasculitis with Nephritis.
Saito A; Komatsuda A; Kaga H; Sato R; Togashi M; Okuyama S; Wakui H; Takahashi N
Tohoku J Exp Med; 2016 Nov; 240(3):199-208. PubMed ID: 27818460
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective.
Sugurmar ANK; Mohd R; Shah SA; Neoh HM; Cader RA
BMC Nephrol; 2021 Apr; 22(1):145. PubMed ID: 33882859
[TBL] [Abstract][Full Text] [Related]
13. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
[TBL] [Abstract][Full Text] [Related]
14. Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis.
Jia M; Zhu L; Zhai YL; Chen P; Xu BY; Guo WY; Shi SF; Liu LJ; Lv JC; Zhang H
Nephrology (Carlton); 2020 Jan; 25(1):40-47. PubMed ID: 30838755
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience.
Su Q; Liang Y; Wang N; Dou Z; Rong Z; Zhao X; Yu B; Wang Y; Wang X
Turk J Med Sci; 2021 Oct; 51(5):2683-2689. PubMed ID: 34392671
[TBL] [Abstract][Full Text] [Related]
16. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.
Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859
[TBL] [Abstract][Full Text] [Related]
17. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
19. The Gut-Renal Connection in IgA Nephropathy.
Coppo R
Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
Tang M; Zhang X; Li X; Lei L; Zhang H; Ling C; Ni J; Lv J; Liu X; Chen X
Clin Exp Nephrol; 2021 Jan; 25(1):37-43. PubMed ID: 32935202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
